134. Mecklin JP, Peltomaki P. Genetic changes associated with colon tumor development. Ann Chiru Gynaecol 2000; 89: 211-15.
135. Hoops TC, Traber PG. Molecular pathogenesis of colorectal cancer. Surg Clin North Am. 1997; 11: 609-33.
136. Woodward M, Bordogna W. Cell cycle and cancer. Rev Oncol 2000; 2: 12-22.
137. Barry EL, Baron JA, Grau MV, Wallace K, Haile RW. K- ras mutations in incident sporadic colorectal adenomas. Cancer. 2006; 106 (5): 1036-40.
138. Hsieh JS, Lin SR, Chang MY, Chen FM, LuCY, et al. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg. 2005; 71 (4): 336-46.
139. Kinzler KW, Nilbert MF, Vogelsteins B, Bryam TM, Levy DB, Smith KJ, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 1991; 251: 1366-70.
140. Eppert K, Scherer SW, Ozcelik H. MADRZ maps to 18q21 and encodes a TGF beta-regulated protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86: 543-52.
141. World Medical Association. The Declaration of Helsinki: Recommendations. Guiding Physicians in Biomedical Research Involving human Subjects. Adopted by the 18th World Medical Assembly, Helsinki, Philander, 1964. Revised in 29th World Medical Assembly, Tokyo, 1965.
142. Llanio Navarro R. Gastroenterología: principios básicos y pruebas diagnósticas. La Habana: Ed. Pueblo y Educación; 1991. p.349
143. Van Munster IP, Tangerman A, De Haan AFJ, Nagengast FM. A new method for the determination of the cytotoxicity of bile acids and aqueous phase of stools. The effect of calcium. Eur J Clin Investig. 1993; 23: 773-7.
144. Malchow-Moller A, Arffmann S, LaRusso NF, Krag E. Enzymatic determination of total 3-hydroxy bile acids in faeces. Validation in healthy subjects of a rapid method suitable for clinical routine purpose. Scand J Gastroenterol. 1982; 17: 331-3.
145. Roseleur OJ, Van Gent CM. A simplified method for the determination of steroids in diets and faeces. Clin Chim Acta. 1978; 82: 13-23.
146. Gelb AM, McSherry ChK, Sadowsky JR, Mosbach EH. Tissue bile acids in patients with colon cancer and colonic polyps. Am J Gastroent 1982; 77: 314-17.
147. Kano M, Wada S, Matsumoto M. Human fecal bile acids and fractions with enzyme linked immunosorbent assay. Showa Univ J Med Sci. 1993; 5: 183-91.
148. Coramina VA. Los lípidos: Laboratorio y clínica. Barcelona, 1973 ed. Tory, S. A. p. 1-459.
149. Fausa O, Skalhegg BA. Quantitative determination of bile acids and their conjugates using thin layer chromatography and purified 3 hydroxy-steroid dehydrogenase. Scand J Gastroenterol. 1974; 9: 249-59.
150. Maratka Z. Terminología, definiciones y criterios diagnósticos en endoscopia digestiva. 3ª ed. Madrid: Normed Verlag; 1994. p. 50-55.
151. Ruiz de León A, Sevilla MC, Pérez de la Sierra JA. Anatomía y fisiología del colon. En: Díaz Rubio M editor. Intestino I. Plan de actualización en gastroenterología. Madrid: Ed. Médica Internacional; 1998. V.3. p. 73-5.
152. Modigliani R. Endoscopic management of inflammatory bowel disease. Am J Gastroenterol. 1994; 89 (Suppl 8): 553-65.
153. Modigliani R. Endoscopic assessment of disease activity in IBD. In: Rachmilewitz D; editor. Inflammatory bowel disease-1994. Dordrecht: Kluwer. Academia Publishers, 1994. 124-30.
154. Robbins SL, Ramzi SG, Vinay K, Tuckes C. Anomalías del crecimiento celular. En su: Patología estructural y funcional. 6ª ed. Madrid: McGraw-Hill/ Interamericana, 2000, p 68-76.
155. Rigau J, Saló J. Poliposis rectocolónica. JANO. 1997; 1213: 35-43.
156. Markowitz AJ, Winawer SJ. Management of colorectal polyps. CA Cancer J Clin. 1997; 47: 93-112.
157. Bond JH. Polyp guideline: diagnosis, treatment and surveillance for patients with nonfamilial colorectal polyps. The practice parameters Committee of the American College of Gastroenterology. Ann Intern Med. 1993; 119: 836-43.
158. Winawer SJ, St John DJ, Bond JH, Rozen P, Burt RW, Wage JD, et al. Prevention of colorectal cancer; guidelines based on new data. Bull World Health Organ. 1995; 73: 7-10.
159. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol. 1982; 35: 830-41.
160. Riddell RM, Goldman H, Randsohoff DF. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol. 1983; 14: 931-68.
161. Steven HI, Young SK. Colonic polyps and polyposis syndromes. In: Sleisenger MH, Fedman M, Sharschmidt BF, editors. Gastrointestinal and liver disease. Pathophysiology, diagnosis and management. 6ª ed. Buenos Aires: Panamericana; 1998. p. 1865-87.
162. Waye JD, Lewis BS, Frankel A, Geller SA. Small colon polyps. Am J Gastroenterol. 1988; 83: 120-22.
163. Bosman FT. Dysplasia classification: pathology in disgrace? J Pathol. 2001; 194: 143-4.
164. Mutto T, Bussey HJR, Morson B. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
165. Jass JR, Sabin LH, editors. International histological classification of tumors. Berlin; Springer 1989.
166. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993; 342: 407-11.
167. Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Muller O, Zimber A, Gespach C, Mareel MM. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene. 2002; 21, 6740-50.
168. Dolara P, Cademi G, Salvadori M, Morozzi G, Fabianai R, Cresci A, Dipianesi C, Tvallori G, Russo A, Palli D. Fecal levels of short-chain fatty acids and bile acids as determinants of colonic mucosal cell proliferation in humans. Nutr Cancer. 2002; 42: 186-90.
169. Biasco G, Paganelli GM, Owen RW, Hill MJ. Faecal bile acids and colorectal cell proliferation. The ECP colon cancer Working Group. Eur J Cancer Prev. 1991; 1 (Suppl 2): 63-8.
170. Riddell RM. Premalignant and early malignant lesions in the gastrointestinal tract: definitions, terminology, and problems. Am J Gastroenterol 1996; 91: 864-72.
171. Cooper HS, Deppisch LH, Gourley WK, Kahn EI, Leu R, Marley PN, Pascal RR, et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology. 1995; 108: 1657-65.
172. Todoroki I, Friedman GD, Slattery HL, Chow WH, Persson I, et al. Cholecystectomy and colorectal cancer. Gastroenterology. 1993; 105: 142-47.
173. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterology 2005; 100: 1813-20.
174. Shernhammer ES, Leitzmann MF, Michard DS, Sprizer FE, Giovannucci E, Colditz GA, Fuchs CL. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer. 2003; 88: 79-83.
175. Lallemand RC, Vakil PA, Person P, Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J. 1984; 288: 31-3.
176. Imperiale TF, Wagner DR, Lin CY, Larhn GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000; 343: 169-74.
177. Lieberman DA, Weiss DG, Band JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New Engl J Med. 2000; 343: 162-68.
178. Juste C. Dietary fatty acids, intestinal microbiota and cancer. Bull Cancer. 2005; 92: 708-21.
179. Bruce WR. Recent hypotheses for the origin of cancer. Cancer Res. 1987; 47: 4237-42.
180. Potter JD. Colorectal cancer: molecules and population. J Nat Cancer Inst. 1999; 91: 916-32.
181. Hahn M, Saeger HD, Schackert HK. Hereditary colorectal cancer: clinical consequences of predictive molecular testing. Int J Colorectal Dis. 1999; 14: 184-93.
182. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology.2000; 119: 854-65.
183. Carethers JM. The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol Clin North Am. 1996; 25: 737-54.
184. Inadomi JM, Sannenberg A. The impact of colorectal cancer screening on life expectancy. Gastrointest Endosc. Clin North Am. 2000; 51: 517-23.
185. Fearly J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer Incidence, mortality and prevalence in the European Union 1997; version 4.0. IARC Cancer Base No. 4. Lyon: IARC Press, 1999. [Limited version available from: URL: http;//www-dep.iarc.fr/eucan.html].
186. Martínez C, Sánchez MJ. Registros de cáncer de población en los países europeos de lengua latina del sur de Europa. Comunicación en XXVII Reunión del Grupo Epidemiología y Registros de Cáncer de países de lengua latina. Nápoles, mayo 2002.
187. National Cancer Institute. Surveillance, epidemiology and end results: colon and rectum cancer. [Limited version available from: http//ser.cancer.gav/faststats/ html/inc_colorectal.html] 2005.
188. Fabio L, Lalao R, Effect of age risk on second-primary colorrectal cancer. J Natl Cancer Inst. 2002; 94: 4-7.
189. Rainoldi JL. Epidemiología del cáncer colorrectal. En: Zapata CS, editors. Avances en la Gastroenterología en las América. AIGE. 2005. p. 168-74.
190. Piñol V, Bessa X, Salo J, Elizalde JI, Castells A. La detección precoz del cáncer colorrectal. Med Intg. 2001; 37: 118-26.
191. Nakajima T, Nakagawa Y, Sano A, Okuno T, Takino T. Tissue bile acids in the intestinal mucosa and colonic polyps. Nippon Shokakibyo Gakkai Zasshi. 1983; 80: 1814.
192. Nakashima T, Sero Y, Nakajima T, Shima T, Sakamoto Y, Sano A, Takino T. Distribution of tissue bile acids in the human alimentary tract and colon polyps. Jpn J Med. 1989; 28: 25-9.
193. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol 1999; 26: 324-37.
194. Rainey JB, Davis PW, Bristol JB, Willianson RC. Adaptation and carcinogenesis in dysfunction rat colon: divergent effects of faeces and bile acids. Br J Cancer. 1983; 48: 477-84.
195. Vennit S. Mutagens in human faeces and cancer of the large bowel en: Rowland IR, editors.: Role of the gut flora in toxicity and cancer. London: Academic Press; 1988. p. 399-460.
196. Hladik V, Nozicka Z, Maslowska M. Colorectal carcinoma and cholecystectomy. Neoplasma 1987; 34: 361-6.
197. Launoy G, Pottier D, Gignoux M. Cancer du côlon proximal et cancer du côlon distal: deux cancers épidémiologiquement différerent. Gastroenterol Clin Biol. 1989; 13: 255-59.
198. Alley PG, Mc Nee RK. Age and sex differences in right colon cancer. Dis Colon Rectum. 1986; 29: 227-9.
199. Vobecky J, Leduc C, Devroede G. Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer. 1984: 54; 3065-69.
200. Leslie A, Carey FA, Pratt NR. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002; 89: 845-60.
201. Wynder EL, Reddy BS. Metabolic epidemiology of colorectal cancer. Cancer.1974; 34: 801-6.